Epidemiological aspects of neoplasms in diabetes - PubMed (original) (raw)
Review
Epidemiological aspects of neoplasms in diabetes
Antonio Nicolucci. Acta Diabetol. 2010 Jun.
Abstract
Glucose metabolism represents a complex system, and several components of the regulatory metabolic pathways may induce abnormalities in cellular growth and regulation. The strongest evidence of an association between glucose metabolism alterations and cancer derives from cohort studies, showing increased cancer incidence and mortality in the presence of diabetes. In particular, several studies clearly indicate an association between type 2 diabetes and the risk of colorectal, pancreatic, and breast cancer. An increased risk of liver, gastric, and endometrial malignancies has also been suggested. Type 1 diabetes is associated with an elevated risk of female reproductive organs and gastric cancers. The risk of malignancies is also increased at earlier stages of glucose metabolism abnormalities, with a linear relationship between cancer risk and plasma insulin levels, usually elevated in the presence of metabolic syndrome or diabetes. The prevalence of diabetes and obesity is rapidly increasing worldwide; if these conditions are associated even with a small increase in the risk of cancer, this will translate into important consequences for public health.
Similar articles
- [Diabetes and cancer: an injurious association].
Gariani K, Tran C, Philippe J. Gariani K, et al. Rev Med Suisse. 2010 Jun 9;6(252):1193-4, 1196-8. Rev Med Suisse. 2010. PMID: 20614754 French. - Illuminating the diabetes-cancer link.
Brower V. Brower V. J Natl Cancer Inst. 2012 Jul 18;104(14):1048-50. doi: 10.1093/jnci/djs322. Epub 2012 Jul 9. J Natl Cancer Inst. 2012. PMID: 22781433 No abstract available. - Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
Larsson SC, Orsini N, Wolk A. Larsson SC, et al. J Natl Cancer Inst. 2005 Nov 16;97(22):1679-87. doi: 10.1093/jnci/dji375. J Natl Cancer Inst. 2005. PMID: 16288121 - Review article: steatosis, the metabolic syndrome and cancer.
Bugianesi E. Bugianesi E. Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:40-3. doi: 10.1111/j.1365-2036.2005.02594.x. Aliment Pharmacol Ther. 2005. PMID: 16225471 Review. - Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Herrigel DJ, Moss RA. Herrigel DJ, et al. Postgrad Med. 2014 Oct;126(6):106-18. doi: 10.3810/pgm.2014.10.2825. Postgrad Med. 2014. PMID: 25414939 Review.
Cited by
- Effects of Alterations in Acid-Base Effects on Insulin Signaling.
Frassetto LA, Masharani U. Frassetto LA, et al. Int J Mol Sci. 2024 Feb 27;25(5):2739. doi: 10.3390/ijms25052739. Int J Mol Sci. 2024. PMID: 38473990 Free PMC article. Review. - Cancer biology in diabetes update: Focusing on antidiabetic drugs.
Kawakita E, Kanasaki K. Kawakita E, et al. J Diabetes Investig. 2024 May;15(5):525-540. doi: 10.1111/jdi.14152. Epub 2024 Mar 8. J Diabetes Investig. 2024. PMID: 38456597 Free PMC article. Review. - The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab.
Mallardo D, Woodford R, Menzies AM, Zimmer L, Williamson A, Ramelyte E, Dimitriou F, Wicky A, Wallace R, Mallardo M, Cortellini A, Budillon A, Atkinson V, Sandhu S, Olivier M, Dummer R, Lorigan P, Schadendorf D, Long GV, Simeone E, Ascierto PA. Mallardo D, et al. J Transl Med. 2023 Oct 25;21(1):753. doi: 10.1186/s12967-023-04607-4. J Transl Med. 2023. PMID: 37880788 Free PMC article. - Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study.
Spoerl S, Gerken M, Schimnitz S, Taxis J, Fischer R, Lindner SR, Ettl T, Ludwig N, Spoerl S, Reichert TE, Spanier G. Spoerl S, et al. Curr Oncol. 2022 Dec 7;29(12):9660-9670. doi: 10.3390/curroncol29120758. Curr Oncol. 2022. PMID: 36547172 Free PMC article. - Racial/Ethnic Disparities of Cancer, Metabolic Syndrome, and Lifestyle Behaviors in People under 50: A Cross-Sectional Study of Data from the National Health and Nutrition Examination Survey.
Zhu L, Rahman A, Yeh MC, Ma GX. Zhu L, et al. Epidemiologia (Basel). 2022 Nov 3;3(4):493-501. doi: 10.3390/epidemiologia3040037. Epidemiologia (Basel). 2022. PMID: 36416800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical